Interpace Biosciences

New Zealand
Hamilton, Waikato Region, New Zealand, 08619

Company profile

Interpace Biosciences company profile

Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Their Interpace Diagnostics business unit provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services, including such widely respected tests as PancraGen®, ThyGeNext®, ThyraMir®, RespriDX® and BarreGen®.

Business identity

Contact email
[email protected]
Phone number
+64 (215)525-5207
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$1M-$10M
Founded
1986-01-01, Year

Headquarters

Postal code
08619
Country code
NZ
Continent
Oceania

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$70.1M
Last funding
Post IPO Equity / $20M / 2020-01-13
Last equity funding
Post IPO Equity / $20M
Investors
2
Lead investors
2
Articles
29
Exited on
1998-05-22

Founders and investors

Lead investors

1315 CapitalAmpersand Capital Partners

Investors

1315 CapitalAmpersand Capital Partners